DIATOR Study Group Selected Research

Atorvastatin (Lipitor)

1/2012	Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial).
3/2011	Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

DIATOR Study Group Research Topics

Disease

3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2013 - 03/2011
1	Inflammation (Inflammations) 01/2012

Drug/Important Bio-Agent (IBA)

2	Atorvastatin (Lipitor)FDA Link 01/2012 - 03/2011
2	AutoantibodiesIBA 01/2012 - 03/2011
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2013
1	ChemokinesIBA 01/2013
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2013
1	CytokinesIBA 01/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012

Therapy/Procedure

1	Aftercare (After-Treatment) 03/2011